Aumento das internações por síndrome de Guillain-Barré no Brasil: estudo ecológico*

Malta, Juliane Maria Alves Siqueira; Ramalho, Walter Massa

doi:10.5123/s1679-49742020000400020

Cited by 5 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…2022 made in São Paulo state found that GBS incidence is 0,6 cases every 100,000 people, but a study made in Rio Grande do Norte state found its incidence of 0,3 cases every 100,000 people. [7] There are many reports of outbreaks of the syndrome. One of these outbreaks happened in the US, following the swine influenza vaccination program in 1976.…”

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

“…[5] In 2015, in Brazil, The Nation Program of Dengue Control of the Ministério da Saúde also registered an increase in the number of hospitalizations due to GBS. [7] The study related this increase to the chikungunya epidemic in the country and the fast spread of zika virus. [7] GBS incidence is higher in men and in Caucasian, but it can affect males and females of all ages and races.…”

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

“…[7] The study related this increase to the chikungunya epidemic in the country and the fast spread of zika virus. [7] GBS incidence is higher in men and in Caucasian, but it can affect males and females of all ages and races. There is no explanation for this prevalence.…”

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

“…[5] Approximately 25% of the GBS cases end up with respiratory failure, 5% in death and 20% in definite significant disability. [7]…”

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

See 3 more Smart Citations

Guillain Barré syndrome and Coronavirus infection / Síndrome de Guillain Barré e infecção por Coronavírus

Bernis¹,

Azevedo²,

Pereira³

et al. 2022

Braz. J. Hea. Rev.

View full text Add to dashboard Cite

The coronavirus (COVID-19) pandemic is a major problem of public health worldwide since 2020. The virus that first started causing pneumonia in Wuhan, China, has spread throughout all six continents and is now also known for causing other health issues, including neurological infection. In the last months, there were many case reports of Guillain-Barré Syndrome (GBS) in patients with SARS-CoV-2 infection, raising concerns over a possible association. The coronavirus infiltrated in neuronal tissue is able to modify the pathophysiology of GBS, that is a polyneuropathy and also an autoimmune disease, commonly triggered by infections of the human body. Acute inflammatory demyelinating polyneuropathy (AIDP) is one of the most common types of demyelinating polyneuropathy, causing loss of the myelin sheath, what makes electrical messages cannot travel between the brain and the periphery of the body. This association must be early diagnosed so that the physician can manage it to avoid respiratory depression and other consequences of the condition.

show abstract

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

“…[5] Approximately 25% of the GBS cases end up with respiratory failure, 5% in death and 20% in definite significant disability. [7]…”

Section: Pathophysiology Of Guillain Barre Syndromementioning

confidence: 99%

See 2 more Smart Citations

Guillain Barré syndrome and Coronavirus infection / Síndrome de Guillain Barré e infecção por Coronavírus

Bernis¹,

Azevedo²,

Pereira³

et al. 2022

Braz. J. Hea. Rev.

View full text Add to dashboard Cite

show abstract

“…A síndrome de Guillain-Barré (SGB) é a causa mais comum de neuropatia flácida e paralítica aguda (WILLISON; JACOBS; VAN DOORN, 2016), gerando cerca de 1500 internações ao ano no Brasil e com aumento a cada ano (MALTA; RAMALHO, 2020). Ao redor do mundo, calcula-se que 100.000 pessoas apresentem a SGB todos os anos, com uma incidência de 0.4-2:100.000 habitantes (WILLISON; JACOBS; VAN DOORN, 2016).…”

Section: Epidemiologiaunclassified

Síndrome de Guillain-Barré / Guillain-Barré Syndrome

Manfroi¹,

Dalari²

2022

Braz. J. Hea. Rev.

View full text Add to dashboard Cite

A síndrome de Guillain-Barré (SGB) é a causa mais comum de neuropatia flácida e paralítica aguda, gerando cerca de 1500 internações ao ano no Brasil e com aumento a cada ano. A sua etiologia é incerta, entretanto, a SGB é considerada uma neuropatia imuno-mediada pós infecciosa, sendo desencadeada após infecções virais e bacterianas. Em sua apresentação típica, ocorre uma fraqueza bilateral e rapidamente progressiva em pernas e/ou braços, que não é explicada por outras causas e não cursa com acometimento do sistema nervoso central. Em 70% dos casos, os sintomas são precedidos por pródromos respiratórios ou gastrointestinais em 1 a 6 semanas. O diagnóstico é eminentemente clínico com complementação de exames laboratoriais e eletrofisiológicos. Os tratamentos mais utilizados são a imunoglonulina intravenosa e plasmaférese, com a adição de suporte ventilatório se necessário.

show abstract

Is there an association of lifestyle habits, anxiety, and depression between incontinent and continent women during COVID-19 pandemic?

et al. 2021

View full text Add to dashboard Cite

Aumento das internações por síndrome de Guillain-Barré no Brasil: estudo ecológico*

Cited by 5 publications

References 12 publications

Guillain Barré syndrome and Coronavirus infection / Síndrome de Guillain Barré e infecção por Coronavírus

Guillain Barré syndrome and Coronavirus infection / Síndrome de Guillain Barré e infecção por Coronavírus

Síndrome de Guillain-Barré / Guillain-Barré Syndrome

Is there an association of lifestyle habits, anxiety, and depression between incontinent and continent women during COVID-19 pandemic?

Contact Info

Product

Resources

About